Banco Bilbao Vizcaya Argentaria S.A. lifted its position in The Allstate Corporation (NYSE:ALL – Free Report) by 72.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 75,113 shares of the insurance provider’s stock after buying an additional 31,636 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Allstate were worth $16,123,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. lifted its stake in Allstate by 79.7% in the third quarter. Harbor Capital Advisors Inc. now owns 124 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 55 shares during the last quarter. Barnes Dennig Private Wealth Management LLC increased its stake in shares of Allstate by 112.3% during the 3rd quarter. Barnes Dennig Private Wealth Management LLC now owns 138 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 73 shares during the last quarter. Clearstead Trust LLC raised its holdings in shares of Allstate by 3,800.0% in the 2nd quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 152 shares during the period. Armstrong Advisory Group Inc. raised its holdings in shares of Allstate by 72.0% in the 3rd quarter. Armstrong Advisory Group Inc. now owns 160 shares of the insurance provider’s stock valued at $34,000 after purchasing an additional 67 shares during the period. Finally, South Plains Financial Inc. lifted its stake in Allstate by 41.5% in the 3rd quarter. South Plains Financial Inc. now owns 167 shares of the insurance provider’s stock valued at $36,000 after purchasing an additional 49 shares during the last quarter. 76.47% of the stock is owned by institutional investors.
Allstate Stock Up 0.6%
Allstate stock opened at $206.22 on Monday. The company’s 50-day moving average price is $204.52 and its two-hundred day moving average price is $204.71. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.26. The stock has a market cap of $53.52 billion, a P/E ratio of 5.40, a P/E/G ratio of 0.43 and a beta of 0.23. The Allstate Corporation has a twelve month low of $176.00 and a twelve month high of $216.75.
Allstate Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $1.08 dividend. This is a boost from Allstate’s previous quarterly dividend of $1.00. The ex-dividend date is Monday, March 2nd. This represents a $4.32 annualized dividend and a yield of 2.1%. Allstate’s dividend payout ratio is presently 11.31%.
Insider Buying and Selling
In other Allstate news, insider Suren Gupta sold 19,593 shares of the stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $210.00, for a total transaction of $4,114,530.00. Following the transaction, the insider owned 100,646 shares in the company, valued at $21,135,660. This trade represents a 16.30% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.70% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
ALL has been the subject of a number of research analyst reports. Evercore set a $225.00 price target on Allstate in a report on Wednesday, January 7th. Roth Mkm upped their price objective on Allstate from $230.00 to $240.00 and gave the company a “buy” rating in a research note on Wednesday, November 26th. Citigroup raised their price objective on Allstate from $216.00 to $221.00 and gave the company a “neutral” rating in a research report on Tuesday, February 10th. Cantor Fitzgerald reissued a “neutral” rating and set a $220.00 target price on shares of Allstate in a report on Thursday, February 5th. Finally, Mizuho increased their price target on Allstate from $255.00 to $281.00 and gave the company an “outperform” rating in a research note on Monday, February 9th. Three equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $238.88.
Get Our Latest Analysis on Allstate
Allstate Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Recommended Stories
- Five stocks we like better than Allstate
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
